{"id":"fenoldopam-infusion","safety":{"commonSideEffects":[{"rate":"3-5%","effect":"Tachycardia"},{"rate":"1-3%","effect":"Headache"},{"rate":"1-3%","effect":"Flushing"},{"rate":"1-2%","effect":"Nausea"},{"rate":"1-2%","effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fenoldopam selectively binds to dopamine-1 receptors on vascular smooth muscle and renal vasculature, leading to peripheral and renal vasodilation. This results in decreased systemic vascular resistance, lowered blood pressure, and increased renal perfusion, making it useful for acute hypertensive episodes and renal protection in critical care settings.","oneSentence":"Fenoldopam is a selective dopamine-1 (DA1) receptor agonist that causes vasodilation and increases renal blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:46:20.726Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypertension in hospitalized patients"},{"name":"Hypertensive emergency"}]},"trialDetails":[{"nctId":"NCT02620761","phase":"PHASE2, PHASE3","title":"Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2019-02-06","conditions":"Patent Ductus Arteriosus (PDA), Acute Kidney Injury (AKI)","enrollment":1},{"nctId":"NCT00743106","phase":"NA","title":"The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2002-09","conditions":"Partial Nephrectomy","enrollment":90},{"nctId":"NCT00557219","phase":"PHASE3","title":"Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery","status":"TERMINATED","sponsor":"Medical University of Gdansk","startDate":"2008-04","conditions":"Acute Renal Failure","enrollment":60},{"nctId":"NCT01073189","phase":"PHASE4","title":"Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury","status":"WITHDRAWN","sponsor":"Southeast Renal Research Institute","startDate":"2010-04","conditions":"Kidney Failures, Acute","enrollment":""},{"nctId":"NCT00592150","phase":"PHASE1","title":"Effect of Gene Variants on Dopamine Receptor Natriuretic Responses","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2007-06","conditions":"Hypertension","enrollment":44},{"nctId":"NCT01690832","phase":"PHASE4","title":"Fenoldopam for Prevention of Acute Kidney Injury","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2012-09","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT00982527","phase":"PHASE3","title":"Fenoldopam in Pediatric Cardiac Surgery","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2009-09","conditions":"Kidney Failure, Acute","enrollment":80},{"nctId":"NCT01324245","phase":"NA","title":"Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2002-11","conditions":"Salt-sensitive Hypertension","enrollment":45},{"nctId":"NCT00747331","phase":"PHASE4","title":"Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2008-09","conditions":"Cardiac Complications, Cardiopulmonary Bypass","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":58,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fenoldopam administration (0.08 mcg/Kg/min)"],"phase":"marketed","status":"active","brandName":"fenoldopam infusion","genericName":"fenoldopam infusion","companyName":"University of Roma La Sapienza","companyId":"university-of-roma-la-sapienza","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fenoldopam is a selective dopamine-1 (DA1) receptor agonist that causes vasodilation and increases renal blood flow. Used for Acute hypertension in hospitalized patients, Hypertensive emergency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}